We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Sues Pharmacy Over “Bait And Switch” Tactic With Popular Asthma Drug

Law360 (September 6, 2005, 12:00 AM EDT) -- AstraZeneca has sued a manufacturer for trademark infringement and false advertising under the Lanham Act, alleging a copycat version of its inhaled asthma medication Pulmicort Respules is forced on unsuspecting customers.

Connecticut-based Broncho-Dose is a mail order “repertory pharmacy” that allegedly engages in the “often abused practice” of pre-mixing its own non-FDA-approved drugs, according to the complaint. Broncho then distributes the drugs as substitutes for various products, including the product in this suit.

Delaware-based AstraZeneca does not allege the Broncho version of the medication is too...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.